Torsten Schwede, a current member of the President’s Board of the University, is set to lead one of Switzerland's most important academic bodies. The chemist heads a research group for structural bioinformatics at the…
Torsten Schwede has been appointed the new Vice President for Research at the University of Basel. The University Council has approved this election. Schwede studied chemistry in Bayreuth and completed his PhD in structural…
Prof. Torsten Schwede The ICSB honors Torsten Schwede, Professor of Structural Bioinformatics at the Biozentrum and Vice President for Research of the University of Basel, for his substantial contributions to computational…
In the past years, AlphaFold has revolutionised protein science. This Artificial Intelligence (AI) tool was trained on protein data collected by life scientists for over 50 years, and is able to predict the 3D shape of…
2023 was a year of significant scientific discoveries and exciting community activities. A major highlight was our first World Alumni Day, celebrating our global community and renewing as well as fostering connections. More…
T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…
The objectives of the National Center of Competence in Research (NCCR) "AntiResist" are to search for new antibiotics and to develop alternative strategies to combat antibiotic-resistant pathogens. "AntiResist" is one of a…
Did the development of an artificial intelligence (AI) tool like ChatGPT surprise you personally? I think we were all surprised by the rapid pace of this development and above all by the quality and versatility of this chat…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.
